Related Experiment Video

Updated: Aug 9, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

[The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in

S C de Greeff1, H E de Melker, L Spanjaard

  • 1Rijksinstituut voor Volksgezondheid en Milieu, Centrum voor Infectieziekten Epidemiologie, Postbus 1, 3720 BA Bilthoven. sabine.de.greeff@rivm.nl

Nederlands Tijdschrift Voor Geneeskunde
|June 26, 2003
PubMed

Insights

The 2002 meningococcal C vaccination campaign in the Netherlands rapidly reduced disease incidence. This public health intervention significantly lowered cases of meningococcal C disease across all age groups.

Area of Science:

  • Epidemiology
  • Immunization
  • Bacteriology

Context:

  • Group C meningococcal disease posed a significant public health challenge in the Netherlands.
  • Large-scale vaccination campaigns are critical public health interventions for controlling infectious diseases.

Purpose:

  • To evaluate the immediate impact of a targeted vaccination campaign on the incidence of Neisseria meningitidis serogroup C disease.
  • To assess the effectiveness of the 2002 vaccination strategy across different age demographics in the Netherlands.

Summary:

  • A descriptive study analyzed patient data from January 1999 to January 2003 to determine disease incidence and serogroup distribution.
  • Following the June-July and September-November 2002 vaccination campaigns, a substantial decline in meningococcal C disease incidence was observed.
  • The incidence of meningococcal C disease decreased by up to 89% in vaccinated age groups, with a notable reduction in the overall proportion of serogroup C cases.

Impact:

  • The vaccination campaign demonstrated rapid and significant success in reducing the burden of meningococcal serogroup C disease.
  • Findings highlight the effectiveness of mass vaccination programs in controlling bacterial meningitis outbreaks.
  • The study provides crucial data for informing future public health strategies against meningococcal disease.
Abstract

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...